< Arab Finance - News - Memphis Pharmaceutical turns to profitability in Q1 2022/2023
Count Down to relaunch



Memphis Pharmaceutical turns to profitability in Q1 2022/2023

Memphis Pharmaceutical turns to profitability in Q1 2022/2023

Arab FinanceMemphis Pharmaceutical (MPCI) turned to profitability in the first quarter (Q1) of fiscal year (FY) 2022/2023, according to the financial income statement filed to the Egyptian Exchange (EGX) on November 14th.

The company recorded a net profit after tax of EGP 12.66 million during the three-month period ended September 30th, versus a net loss of EGP 4.41 million in the same quarter of FY 2021/2022.

Memphis is one of the oldest pharmaceutical and chemical companies in the Middle East and has been in the market since 1940.

 

Recommended Stocks

13 Jun 2022
Delta Sugar SUGR
Close
22.35
Change
-03.54
Hold

All rights reserved to Arab Finance 2020 ©

Back to top